Guggenheim Capital’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-119,705
Closed -$2.15M 1976
2020
Q2
$2.15M Buy
119,705
+49,420
+70% +$889K 0.02% 855
2020
Q1
$501K Sell
70,285
-13,797
-16% -$98.3K 0.01% 1369
2019
Q4
$2.01M Buy
84,082
+18,170
+28% +$434K 0.02% 1041
2019
Q3
$1.77M Sell
65,912
-5,056
-7% -$136K 0.01% 1065
2019
Q2
$1.93M Sell
70,968
-810
-1% -$22K 0.02% 1073
2019
Q1
$2.49M Sell
71,778
-20,948
-23% -$727K 0.02% 979
2018
Q4
$1.81M Sell
92,726
-839
-0.9% -$16.4K 0.02% 1093
2018
Q3
$2.49M Buy
93,565
+17,835
+24% +$475K 0.02% 1115
2018
Q2
$2.86M Sell
75,730
-3,624
-5% -$137K 0.02% 1033
2018
Q1
$2.59M Buy
79,354
+11,544
+17% +$377K 0.01% 1447
2017
Q4
$3.3M Sell
67,810
-52,552
-44% -$2.56M 0.01% 1286
2017
Q3
$6.5M Buy
120,362
+34,213
+40% +$1.85M 0.02% 902
2017
Q2
$4.84M Buy
86,149
+9,820
+13% +$552K 0.01% 1031
2017
Q1
$2.99M Sell
76,329
-21,778
-22% -$854K 0.01% 1352
2016
Q4
$2.2M Sell
98,107
-5,372
-5% -$121K 0.01% 1601
2016
Q3
$2.35M Buy
103,479
+1,673
+2% +$38K 0.01% 1517
2016
Q2
$2.4M Buy
101,806
+5,157
+5% +$122K 0.01% 1449
2016
Q1
$1.97M Sell
96,649
-13,789
-12% -$281K 0.01% 1580
2015
Q4
$5.68M Sell
110,438
-39,690
-26% -$2.04M 0.02% 956
2015
Q3
$6.4M Sell
150,128
-15,988
-10% -$681K 0.02% 927
2015
Q2
$7.57M Buy
166,116
+15,406
+10% +$702K 0.02% 965
2015
Q1
$5.72M Buy
150,710
+13,711
+10% +$520K 0.01% 1102
2014
Q4
$3.88M Buy
+136,999
New +$3.88M 0.01% 1267